Abstract In 2019, cardiovascular disease (CVD) accounted for 46.74% and 44.26% of all
deaths in rural and urban areas, respectively. Two out of every five deaths were attributed to …

Abstract In 2019, cardiovascular disease (CVD) accounted for 46.74% and 44.26% of all
deaths in rural and urban areas, respectively. Two out of every five deaths were due to CVD …

Hypertension is one of the leading causes of disability-adjusted life years and mortality, with
approximately 15% prevalence worldwide. Most patients with hypertension from low-to high …

Lower-middle income Indonesia, the world's fourth most populous country, has struggled to
contain costs in its mandatory, single-payer public health insurance system since the …

Abstract In 2019, cardiovascular disease (CVD) accounted for 46.74% and 44.26% of all
deaths in rural and urban areas, respectively. Two out of every five deaths were attributed to …

Objective To evaluate the impact of the first round of the National Centralized Drug
Procurement (NCDP) pilot (referred to as “4+ 7” policy) on the use of policy-related original …

Atenolol is one of the cardioselective β-blocker drugs widely used to treat cardiovascular
disease. Atenolol is available under different trade names and marketed by several generic …

A rapid approach, with the association of Fourier‐transform infrared spectroscopy (FTIR) and
nuclear magnetic resonance spectroscopy (NMR), is proposed in order to provide a fast …

Introdução: A Hipertensão Arterial é uma doença crónica e o principal fator de risco para as
doenças cardiovasculares cuja prevalência tem vindo a aumentar em todo o mundo. A …

The problem of using generics in the treatment of patients with cardiovascular diseases
remains relevant for more than a decade. The concern of doctors, pharmacists and patients …